Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Form 8.3 - TED BAKER PLC

17 Oct 2022 12:19

RNS Number : 1320D Barclays PLC 17 October 2022 160

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Coe (the "Coe")

1.

KEY INFORMATION

(a)

Full name of iscloser:

160

Barclays PLC.

(b)

Owner or controller of interest an short

160

160

positions isclose, if ifferent from 1(a):

(c)

Name of offeror/offeree in relation to whose

TED BAKER PLC

160

relevant securities this form relates:

()

If an exempt fun manager connecte with an

160

160

offeror/offeree, state this an specify ientity of

160

offeror/offeree:

(e)

Date position hel/ealing unertaken:

14 Oct 2022

(f)

In aition to the company in 1(c) above, is the iscloser making

NO

160

160

160

isclosures in respect of any other party to the offer?

160

160

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests an short positions in the relevant securities of the offeror or offeree

160

160

to which the isclosure relates following the ealing(if any)

160

Class of relevant security:

p orinary

160

Interests

Short Positions

160

Number

(%)

Number

(%)

(1)

Relevant securities owne

160

160

160

160

160

an/or controlle:

160

160

8,169,716

4.43%

7,126

0.30%

(2)

Cash-settle erivatives:

160

160

160

160

160

an/or controlle:

160

160

218,094

0.12%

7,611,219

4.12%

(3)

Stock-settle erivatives (incluing options)

160

160

160

160

160

an agreements to purchase/sell:

160

160

0

0.00%

0

0.00%

160

160

160

160

160

160

160

160

160

TOTAL:

160

160

8,387,810

4.4%

8,168,34

4.42%

(b)

Rights to subscribe for new securities (incluing irectors an other executive

160

160

options)

160

160

160

160

160

160

Class of relevant security in relation to

160

160

160

160

which subscription right exists

160

160

160

160

Details, incluing nature of the rights

160

160

160

160

concerne an relevant percentages:

160

160

160

160

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases an sales

160

160

160

160

160

Class of relevant

Purchase/sale

Number of

Price per unit

security

160

securities

160

p orinary

Purchase

36

1.0999160 GBP

p orinary

Purchase

1,261

1.1000160 GBP

p orinary

Purchase

4,40

1.0980160 GBP

p orinary

Purchase

2,71

1.0982160 GBP

p orinary

Sale

36

1.1000160 GBP

p orinary

Sale

3,782

1.0976160 GBP

160

160

160

160

160

160

160

160

(b)

Cash-settle erivative transactions

160

Class of

Prouct

Nature of ealing

Number of

Price per

relevant

escription

160

reference

unit

security

160

160

securities

160

p orinary

SWAP

Long

2,097

1.0982160 GBP

p orinary

SWAP

Long

4,240

1.1000160 GBP

p orinary

SWAP

Long

29,44

1.0972160 GBP

p orinary

SWAP

Short

1,422

1.1000160 GBP

p orinary

SWAP

Short

4,687

1.0980160 GBP

p orinary

SWAP

Short

1,182

1.0982160 GBP

160

160

160

160

160

160

160

160

(c)

Stock-settle erivative transactions (incluing options)

160

(i)

Writing, selling, purchasing or varying

160

Class

Prouct

Writing,

Number

Exercise

Type

Expiry

Option

of

escription

purchasing,

of

price

160

ate

money

relevant

160

selling,

securities

per unit

160

160

pai/

security

160

varying etc

to which

160

160

160

receive

160

160

160

option

160

160

160

per unit

160

160

160

relates

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

(ii)

Exercising

160

160

160

160

160

160

Class of relevant

Prouct escription

Exercising/ exercise against

Number of

Exercise price per

security

160

160

securities

unit

160

160

160

160

160

160

160

160

160

160

160

160

160

()

Other ealings (incluing subscribing for new securities)

160

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

160

160

applicable)

160

160

160

160

4.

OTHER INFORMATION

(a)

Inemnity an other ealings arrangements

160

Details of any inemnity or option arrangement, or any agreement or unerstaning,

160

160

formal or informal, relating to relevant securities which may be an inucement to eal

160

160

or refrain from ealing entere into by the exempt principal traer making the isclosure an any party

160

to the offer or any person acting in concert with a party to the offer:

160

160

160

NONE

(b)

Agreements, arrangements or unerstanings relating to options or erivatives

160

Details of any agreement, arrangement or unerstaning, formal or informal, between

160

160

the person making the isclosure an any other person relating to:

160

160

(i)160 the voting rights of any relevant securities uner any option or

160

160

160

(ii) the voting rights of future acquisition or isposal of any relevant securities to which

160

160

any erivative is reference:

160

160

160

160

160

160

NONE

(c)

Attachments

160

160

160

160

160

160

Is a Supplemental Form 8 (Open Positions) attache?

NO

Date of isclosure:

17 Oct 2022

Contact name:

Large Holings Regulatory Operations

Telephone number:

020 3134 7213

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

160

This information is provie by RNS, the news service of the Lonon Stock Exchange. RNS is approve by the Financial Conuct Authority to act as a Primary Information Provier in the Unite Kingom. Terms an conitions relating to the use an istribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP aress to confirm compliance with the terms an conitions, to analyse how you engage with the information containe in this communication, an to share such analysis on an anonymise basis with others as part of our commercial services. For further information about how RNS an the Lonon Stock Exchange use the personal ata you provie us, please see our Privacy Policy.160 END160160RETBBBDGIBBDGDR
Date   Source Headline
18th Mar 20228:20 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSStatement re Possible Offer
7th Mar 20221:01 pmRNSHolding(s) in Company
23rd Feb 20227:00 amRNSQ4 2022 / Pre-close trading update
17th Dec 20213:04 pmRNSBoard composition
6th Dec 20217:00 amRNSJohn Barton
1st Dec 20214:56 pmRNSTotal Voting Rights
11th Nov 202110:48 amRNSReplacement Interim Results
11th Nov 20217:00 amRNSInterim Results
5th Nov 202112:04 pmRNSDirectorate Change
2nd Nov 20213:13 pmRNSBlock listing Interim Review
6th Oct 20214:17 pmRNSDirector/PDMR Shareholding
4th Oct 20217:00 amRNSNew Joint Broker
7th Sep 20217:00 amRNSQ2 Trading Update
4th Aug 20217:00 amRNSDirectorate Change
3rd Aug 202111:22 amRNSDirector/PDMR Shareholding
28th Jul 20213:12 pmRNSNotice of Results
28th Jul 20217:00 amRNSNotice of Q2 Trading Update
23rd Jul 20217:00 amRNSNew Global HQ
28th Jun 20217:00 amRNSNotice of AGM
17th Jun 20217:00 amRNSHolding(s) in Company
14th Jun 20217:00 amRNSFinal Results
9th Jun 20213:11 pmRNSChange to Full Year Results Date
25th May 20217:00 amRNSSuccessful bank refinancing
24th May 20217:00 amRNSChange to Full Year Results Date
13th May 20217:00 amRNSHolding(s) in Company
6th May 20212:54 pmRNSBlock listing Interim Review
29th Apr 202110:55 amRNSHolding(s) in Company
11th Mar 20217:00 amRNSTed Baker announces new territory licence deals
24th Feb 202112:30 pmRNSAdditional Listing
11th Feb 20217:00 amRNSNotice of Results
4th Feb 202110:01 amRNSTotal Voting Rights
8th Jan 20213:47 pmRNSNotice of Results
16th Dec 20206:35 pmRNSDirector/PDMR Shareholding
7th Dec 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSChange to Interim Results Date
3rd Nov 20205:07 pmRNSBlock listing Interim Review
2nd Nov 202011:49 amRNSHolding(s) in Company
26th Oct 202010:50 amRNSDirector/PDMR Shareholding
14th Oct 202011:31 amRNSNotice of Results
7th Oct 20204:56 pmRNSHolding(s) in Company
6th Oct 20202:34 pmRNSTotal Voting Rights
30th Sep 202010:17 amRNSDirector/PDMR Shareholding
4th Sep 20202:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20204:26 pmRNSDirector/PDMR Shareholding
1st Sep 202010:10 amRNSDirectorate Change
18th Aug 20205:13 pmRNSDirector/PDMR Shareholding
4th Aug 202011:58 amRNSTotal Voting Rights
24th Jul 20205:54 pmRNSHolding(s) in Company
21st Jul 202012:17 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.